Inflammation treatment may help curb obesity, type 2 diabetes

07/10/2013 | American City Business Journals

Researchers at the University of Georgia's College of Pharmacy have successfully tested several anti-inflammatory compounds in mice that prevented weight gain and reduced the incidence of obesity-related conditions that can lead to type 2 diabetes. In one case, scientists injected mice with a plant pigment called rutin found in fruits and vegetables; in another, the mice were injected with interleukin 10. Both treatments controlled weight, reduced inflammation and prevented early signs of liver disease and diabetes.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park